These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 34329743

  • 1. A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 2: Pathophysiology of calcium disorder and extraosseous calcification.
    Tang PK, Geddes RF, Jepson RE, Elliott J.
    Vet J; 2021 Sep; 275():105718. PubMed ID: 34329743
    [Abstract] [Full Text] [Related]

  • 2. A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 1: Physiology of calcium handling.
    Tang PK, Geddes RF, Jepson RE, Elliott J.
    Vet J; 2021 Sep; 275():105719. PubMed ID: 34311095
    [Abstract] [Full Text] [Related]

  • 3. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S, Giachelli CM.
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [Abstract] [Full Text] [Related]

  • 4. Associations between single nucleotide polymorphisms in the calcium sensing receptor and chronic kidney disease-mineral and bone disorder in cats.
    Geddes RF, Jepson RE, Forcada Y, Elliott J, Syme HM.
    Vet J; 2018 May; 235():34-41. PubMed ID: 29704936
    [Abstract] [Full Text] [Related]

  • 5. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M, Fukagawa M, Kakuta T.
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [Abstract] [Full Text] [Related]

  • 6. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y, Zhang H, Li Y, Li Q, Zuo L.
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [Abstract] [Full Text] [Related]

  • 7. The Importance of Phosphate Control in Chronic Kidney Disease.
    Tsuchiya K, Akihisa T.
    Nutrients; 2021 May 14; 13(5):. PubMed ID: 34069053
    [Abstract] [Full Text] [Related]

  • 8. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.
    Kaur R, Singh R.
    Life Sci; 2022 Dec 15; 311(Pt B):121148. PubMed ID: 36336124
    [Abstract] [Full Text] [Related]

  • 9. The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.
    Hruska KA, Sugatani T, Agapova O, Fang Y.
    Bone; 2017 Jul 15; 100():80-86. PubMed ID: 28119179
    [Abstract] [Full Text] [Related]

  • 10. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H, Joki N.
    Clin Exp Nephrol; 2017 Mar 15; 21(Suppl 1):53-63. PubMed ID: 28062938
    [Abstract] [Full Text] [Related]

  • 11. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA.
    Kidney Int; 2018 Jan 15; 93(1):147-158. PubMed ID: 28843411
    [Abstract] [Full Text] [Related]

  • 12. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.
    Kidney Int; 2018 Jul 15; 94(1):102-113. PubMed ID: 29716795
    [Abstract] [Full Text] [Related]

  • 13. Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis.
    Fan Z, Wei X, Zhu X, Yang K, Tian L, Du Y, Yang L.
    Sci Rep; 2024 Feb 23; 14(1):4477. PubMed ID: 38396063
    [Abstract] [Full Text] [Related]

  • 14. Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
    Chen NX, Srinivasan S, O'Neill K, Nickolas TL, Wallace JM, Allen MR, Metzger CE, Creecy A, Avin KG, Moe SM.
    J Bone Miner Res; 2020 Mar 23; 35(3):608-617. PubMed ID: 31743501
    [Abstract] [Full Text] [Related]

  • 15. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
    Zhang L, Adu IK, Zhang H, Wang J.
    Int Urol Nephrol; 2023 Oct 23; 55(10):2527-2538. PubMed ID: 36964322
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Calcium as a cardiovascular toxin in CKD-MBD.
    Moe SM.
    Bone; 2017 Jul 23; 100():94-99. PubMed ID: 27576942
    [Abstract] [Full Text] [Related]

  • 19. Risk factors and implications associated with ultrasound-diagnosed nephrocalcinosis in cats with chronic kidney disease.
    Tang PK, Geddes RF, Chang YM, Jepson RE, van den Broek DHN, Lötter N, Elliott J.
    J Vet Intern Med; 2024 Jul 23; 38(3):1563-1576. PubMed ID: 38438128
    [Abstract] [Full Text] [Related]

  • 20. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview.
    Izzo C, Secondulfo C, Bilancio G, Visco V, Virtuoso N, Migliarino S, Ciccarelli M, Di Pietro P, La Mura L, Damato A, Carrizzo A, Vecchione C.
    Life (Basel); 2024 Mar 21; 14(3):. PubMed ID: 38541742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.